Regulatory Basis for U.S. Drug - U.S. Track - Document - PDFSEARCH.IO

First Page	Meta Content
	Regulatory Basis for U.S. Drug & Biologics Approval Paul G. Kluetz, M.D. Office of Hematology and Oncology Products 1 Add to Reading List Open Document File Size: 101,63 KB Share Result on Facebook Country United States / / IndustryTerm therapy for the same disease / Therapy for Prostate Cancer / / MedicalCondition same disease / tumor / lung cancer / diseases / radiographic tumor / Prostate Cancer / Breast Cancer / / MedicalTreatment alternative therapy / Photodynamic Therapy / / Organization office of Hematology / FDA / office of Hematology and Oncology Products / Center for Drug Evaluation and Research / Hematology and Oncology Products Center / Center for Devices / FDA Mission / office of Combination Products / / Person Paul G. Kluetz / / Technology Radiation / ultrasound / Antibodies / In Vitro Diagnostics / / SocialTag Clinical research Center for Devices and Radiological Health Center for Drug Evaluation and Research Biologic Center for Biologics Evaluation and Research Surrogate endpoint Clinical trial FDA Fast Track Development Program Federal Food, Drug, and Cosmetic Act Food and Drug Administration

Regulatory Basis for U.S. Drug & Biologics Approval Paul G. Kluetz, M.D. Office of Hematology and Oncology Products 1Add to Reading List